Found: 1
Select item for more details and to access through your institution.
Phase I and pharmacokinetic study of 3′-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 1, p. 316, doi. 10.1007/s10637-010-9535-y
- By:
- Publication type:
- Article